84 related articles for article (PubMed ID: 6667452)
1. CNDO/2 molecular orbital calculations on the antifolate DAMP and some related species: structural geometries, ring distortions, change distributions and conformational characteristics.
Welsh WJ; Cody V; Mark JE; Zakrzewski SF
Cancer Biochem Biophys; 1983 Dec; 7(1):27-38. PubMed ID: 6667452
[TBL] [Abstract][Full Text] [Related]
2. Molecular structures of 2,4-diaminopyrimidine antifolates with antineoplastic activity.
Cody V; Zakrzewski SF
J Med Chem; 1982 Apr; 25(4):427-30. PubMed ID: 7069721
[TBL] [Abstract][Full Text] [Related]
3. Crystallographic studies of the antineoplastic antifolate 2,4-diamino-5-(3',4'-dichlorophenyl)-6-methylpyrimidine (DDMP) ethanesulfonate salt.
Cody V
Cancer Biochem Biophys; 1983; 6(3):173-7. PubMed ID: 6850552
[TBL] [Abstract][Full Text] [Related]
4. Analysis of quinazoline and pyrido[2,3-d]pyrimidine N9-C10 reversed-bridge antifolates in complex with NADP+ and Pneumocystis carinii dihydrofolate reductase.
Cody V; Galitsky N; Luft JR; Pangborn W; Queener SF; Gangjee A
Acta Crystallogr D Biol Crystallogr; 2002 Sep; 58(Pt 9):1393-9. PubMed ID: 12198294
[TBL] [Abstract][Full Text] [Related]
5. Conformational analysis of lipophilic antifolates: crystal and molecular structures of three s-triazine dihydrofolate reductase inhibitors.
Cody V; Sutton PA
Anticancer Drug Des; 1987 Dec; 2(3):253-62. PubMed ID: 3449089
[TBL] [Abstract][Full Text] [Related]
6. Computer graphic modeling in drug design--conformational analysis of antifolate binding to avian dihydrofolate reductase: crystal and molecular structures of 2,4-diamino-5-cyclohexyl-6-methylpyrimidine and 5-cyclohexyl-6-methyluracil.
Cody V; Ciszak E
Anticancer Drug Des; 1991 May; 6(2):83-93. PubMed ID: 2039584
[TBL] [Abstract][Full Text] [Related]
7. Molecular orbital calculations of ring opening of the isoelectronic cyclopropylcarbinyl radical, cyclopropoxy radical, and cyclopropylaminium radical cation series of radical clocks.
Cooksy AL; King HF; Richardson WH
J Org Chem; 2003 Nov; 68(24):9441-52. PubMed ID: 14629170
[TBL] [Abstract][Full Text] [Related]
8. Structural studies on bio-active compounds. Part 9. 2,4-Diamino-6-azidoquinazoline hydrochloride.
Schwalbe CH; King ME; Wong KP; Lambert PA; Bliss A; Stevens MF
Anticancer Drug Des; 1987 Dec; 2(3):289-96. PubMed ID: 3449092
[TBL] [Abstract][Full Text] [Related]
9. Studies with a new antifolate 2,4-diamino-5-adamantyl-6-methylpyrimidine (DAMP): tissue distribution and disposition of 2,4-diamino-5-adamantyl-6-methylpyrimidine and its metabolite.
Zakrzewski SF; Dave C; Mead LH; Deluomo DS
J Pharmacol Exp Ther; 1978 Apr; 205(1):19-26. PubMed ID: 633083
[TBL] [Abstract][Full Text] [Related]
10. Selective Pneumocystis carinii dihydrofolate reductase inhibitors: design, synthesis, and biological evaluation of new 2,4-diamino-5-substituted-furo[2,3-d]pyrimidines.
Gangjee A; Guo X; Queener SF; Cody V; Galitsky N; Luft JR; Pangborn W
J Med Chem; 1998 Apr; 41(8):1263-71. PubMed ID: 9548816
[TBL] [Abstract][Full Text] [Related]
11. Hydration of mononucleotides.
Liu D; Wyttenbach T; Bowers MT
J Am Chem Soc; 2006 Nov; 128(47):15155-63. PubMed ID: 17117867
[TBL] [Abstract][Full Text] [Related]
12. New insights into DHFR interactions: analysis of Pneumocystis carinii and mouse DHFR complexes with NADPH and two highly potent 5-(omega-carboxy(alkyloxy) trimethoprim derivatives reveals conformational correlations with activity and novel parallel ring stacking interactions.
Cody V; Pace J; Chisum K; Rosowsky A
Proteins; 2006 Dec; 65(4):959-69. PubMed ID: 17019704
[TBL] [Abstract][Full Text] [Related]
13. Examination of structural characteristics of the potent oxytocin antagonists [dPen1,Pen6]-OT and [dPen1,Pen6, 5-tBuPro7]-OT by NMR, Raman, CD spectroscopy and molecular modeling.
Bélec L; Blankenship JW; Lubell WD
J Pept Sci; 2005 Jul; 11(7):365-78. PubMed ID: 15641022
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of Escherichia coli thioredoxin reductase refined at 2 A resolution. Implications for a large conformational change during catalysis.
Waksman G; Krishna TS; Williams CH; Kuriyan J
J Mol Biol; 1994 Feb; 236(3):800-16. PubMed ID: 8114095
[TBL] [Abstract][Full Text] [Related]
15. Toxicity and pharmacokinetics of a new antifolate, 2,4-diamino-5-adamantyl-6-methylpyrimidine, in dogs.
Zakrzewski SF; Pavelic Z; Greco WR; Bullard G; Creaven PJ; Mihich E
Cancer Res; 1982 Jun; 42(6):2177-83. PubMed ID: 7074598
[TBL] [Abstract][Full Text] [Related]
16. The conformation of end-groups is one determinant of carotenoid topology suitable for high fidelity molecular recognition: a study of beta- and epsilon-end-groups.
Landrum JT; Chatfield DC; Mebel AM; Alvarez-Calderon F; Fernandez MV
Arch Biochem Biophys; 2010 Jan; 493(2):169-74. PubMed ID: 19850003
[TBL] [Abstract][Full Text] [Related]
17. Conformational preferences of proline analogues with different ring size.
Jhon JS; Kang YK
J Phys Chem B; 2007 Apr; 111(13):3496-507. PubMed ID: 17388495
[TBL] [Abstract][Full Text] [Related]
18. Linkages in tubulin-colchicine functions: the role of the ring C (C') oxygens and ring B in the controls.
Pérez-Ramírez B; Gorbunoff MJ; Timasheff SN
Biochemistry; 1998 Feb; 37(6):1646-61. PubMed ID: 9484236
[TBL] [Abstract][Full Text] [Related]
19. New steroid-fused P-heterocycles. Part I. Synthesis and conformational study of dioxaphosphorino[16,17-d]estrone derivatives.
Frank E; Körtvélyesi T; Czugler M; Mucsi Z; Keglevich G
Steroids; 2007 May; 72(5):437-45. PubMed ID: 17383699
[TBL] [Abstract][Full Text] [Related]
20. Structure determination of tetrahydroquinazoline antifolates in complex with human and Pneumocystis carinii dihydrofolate reductase: correlations between enzyme selectivity and stereochemistry.
Cody V; Luft JR; Pangborn W; Gangjee A; Queener SF
Acta Crystallogr D Biol Crystallogr; 2004 Apr; 60(Pt 4):646-55. PubMed ID: 15039552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
